Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00602381
- Locations
- ๐บ๐ธ
Arkansas Research, Little Rock, Arkansas, United States
Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Intermittent Claudication
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 36
- Registration Number
- NCT00602407
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Infection
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00602498
- Locations
- ๐บ๐ธ
MDS Pharma Services, Phoenix, Arizona, United States
Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Intermittent Claudication
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 32
- Registration Number
- NCT00602173
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Dry Mouth
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00602524
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Terbinafine Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Onychomycosis
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00602251
- Locations
- ๐บ๐ธ
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Dry Mouth
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00601211
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Torsemide Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Edema
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00602303
- Locations
- ๐บ๐ธ
Bio-Kinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Meloxicam Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Inflammation
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 48
- Registration Number
- NCT00601887
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 29
- Registration Number
- NCT00601536
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath